US › Healthcare

Profound Medical Corp (PROF)

US · Healthcare · Medical Devices

$7.21+4.80%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$2.5M

Revenue YoY

+12.3%

Net profit

$-9.5M

EPS

$0.26

EPS estimate

$-0.22

Net margin

-384.2%

EPS came in at 0.26 against a street estimate of -0.22 — a beat of 218.2%.

Key statistics

Market cap

$263.5M

Forward P/E

0.0

P/B

5.03

Book value

$1.83

EPS (TTM)

$-0.99

52-week high

$8.95

52-week low

$4.80

50-day MA

$6.23

200-day MA

$6.65

Beta

0.56

Analyst view

Analysts rate Profound Medical Corp a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $11.14.

Shareholding

Insiders

4.09%

Institutions

45.13%

Largest institutional holders

Fund	Stake
Bank of Montreal	0.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Profound Medical Corp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.